|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,669.50 INR | +0.37% |
|
+1.92% | +2.96% |
| 06-02 | Alkem Laboratories Limited Launches Semaglutide in Single-Shot Pre-Filled Syringes At Price Starting Inr 350 | CI |
| 06-02 | Alkem Laboratories Shows Strong Moves But Weak Follow-Through |  |
| Market Cap | 675B 7.08B 6.19B 5.71B 5.28B 10.02B 10.19B 68.36B 26.8B 332B 26.56B 25.99B 1,149B | P/E 2026 |
27.5x | P/E 2027 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise Value | 647B 6.78B 5.93B 5.47B 5.06B 9.61B 9.77B 65.51B 25.68B 318B 25.46B 24.9B 1,101B | EV / Sales 2026 |
4.3x | EV / Sales 2027 * | 3.95x |
| Free-Float |
37.09% | Yield 2026 |
1% | Yield 2027 * | 0.91% |
Last Transcript: Alkem Laboratories Limited
| 1 day | +0.37% | ||
| 1 week | +1.92% | ||
| Current month | +1.79% | ||
| 1 month | +6.98% | ||
| 3 months | +4.22% | ||
| 6 months | -3.37% | ||
| Current year | +2.96% |
| 1 week | 5,531.5 |  | 5,735 |
| 1 month | 5,262 | | 5,735 |
| Current year | 5,075 | | 5,933.5 |
| 1 year | 4,731.6 | | 5,933.5 |
| 3 years | 3,447 | | 6,439.9 |
| 5 years | 2,828 | | 6,439.9 |
| 10 years | 1,360.6 | | 6,439.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajorshi Ganguli
PSD | President | - | - |
Akhilesh Sharma
PSD | President | - | - |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sandeep Singh
BRD | Director/Board Member | 44 | 09/08/2013 |
| Director/Board Member | 63 | 11/02/2008 | |
Sarvesh Singh
BRD | Director/Board Member | 44 | 11/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.37% | +1.92% | +19.79% | +62.56% | 7.08B | |
| +0.09% | +0.25% | +54.65% | +169.19% | 1,085B | |
| -1.63% | -1.50% | +65.79% | +62.70% | 624B | |
| -1.12% | -4.27% | +31.10% | +84.44% | 442B | |
| +0.98% | -0.59% | +28.75% | +27.65% | 332B | |
| -1.43% | -9.10% | +23.66% | +29.08% | 277B | |
| +0.64% | -2.22% | +26.08% | +45.81% | 282B | |
| +0.41% | -1.73% | -29.48% | -39.49% | 217B | |
| -1.19% | -2.81% | +22.63% | +66.30% | 196B | |
| -0.72% | +2.72% | +19.07% | +81.19% | 167B | |
| Average | -0.05% | -1.41% | +26.20% | +58.94% | 362.9B | |
| Weighted average by Cap. | +0.24% | -1.05% | +38.28% | +85.05% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 146B 1.53B 1.34B 1.24B 1.14B 2.17B 2.21B 14.8B 5.8B 71.81B 5.75B 5.63B 249B | 165B 1.73B 1.52B 1.4B 1.29B 2.45B 2.49B 16.73B 6.56B 81.18B 6.5B 6.36B 281B |
| Net income | 25.13B 263M 230M 212M 196M 373M 379M 2.54B 997M 12.34B 988M 967M 42.74B | 23.59B 247M 216M 199M 184M 350M 356M 2.39B 936M 11.58B 928M 908M 40.12B |
| Net Debt | -28.13B -295M -258M -238M -220M -418M -425M -2.85B -1.12B -13.82B -1.11B -1.08B -47.85B | -21.73B -228M -199M -184M -170M -323M -328M -2.2B -862M -10.67B -855M -836M -36.97B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | ₹5,669.50 | +0.37% | 104,124 |
| 09/07/26 | ₹5,648.50 | +0.76% | 39,730 |
| 08/07/26 | ₹5,606.00 | -1.09% | 101,198 |
| 07/07/26 | ₹5,667.50 | +1.23% | 200,471 |
| 06/07/26 | ₹5,598.50 | +0.65% | 99,065 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALKEM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
